Next Biomedical Co.,Ltd. (KOSDAQ:389650)
South Korea · Delayed Price · Currency is KRW 60,800
-2,600 (-4.10%)
At close: Apr 9, 2026
Next Biomedical Market Cap
Next Biomedical has a market cap or net worth of 546.38 billion as of April 10, 2026. Its market cap has increased by 48.14% in one year.
Market Cap
546.38B
Enterprise Value
517.09B
Revenue
16.48B
Ranking
n/a
PE Ratio
n/a
Stock Price
60,800.00
Market Cap Chart
Since August 20, 2024, Next Biomedical's market cap has increased from 189.79B to 546.38B, an increase of 187.88%. That is a compound annual growth rate of 90.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 9, 2026 | 498.80B | -31.99% |
| Dec 30, 2025 | 733.43B | 121.21% |
| Dec 30, 2024 | 331.55B | 74.69% |
| Aug 20, 2024 | 189.79B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ASTERASYS Co.,Ltd | 389.45B |
| MEDIANA Co.,Ltd | 329.35B |
| L&K Biomed | 172.10B |
| SELVAS Healthcare | 112.39B |
| Remed | 93.80B |
| Neofect | 83.78B |
| Noul Co.,Ltd. | 81.19B |
| Hironic | 74.74B |